Use of health technology assessment in drug reimbursement decisions in China.
Where this comes from
- Record sourced from PubMed, PMID 37321619.
- Also identified by DOI 10.1136/bmj-2021-068915 and PMC identifier 10266437.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
China has made substantial progress in using health technology assessment, but more effort should be made to improve the quality of evidence, strengthen capacity, and enhance transparency, say <b>Wen Chen and colleagues</b>
Medical subject headings
- Technology Assessment, Biomedical
- Decision Making